MSB long way to run in my opinion. Happy to let the NASDAQ again take charge for "their" second day after ~69 million share turnover last night, when their average turnover is 1.5 million.
Hopefully child GHVD treatment paves way for adult GHVD treatment.
Plus meeting with FDA for accelerated approval of their second drug.
As we know with stocks - its all in the timing.
Above is not financial advice and my opinion only.
